This bill adds a new section to the General Laws that prohibits health insurers and pharmacy benefit managers from limiting a patient's choice in obtaining clinician-administered drugs. It prevents them from refusing to authorize or pay a participating provider for providing these drugs and related services, and from imposing additional fees or penalties on patients. The bill also allows health insurers to offer the use of a home infusion pharmacy or an external infusion site for patients to receive clinician-administered drugs in their homes.

The bill aims to give patients the freedom to choose where they obtain their clinician-administered drugs and to prevent health insurers and pharmacy benefit managers from limiting their options or imposing additional costs or penalties. It also aims to ensure that healthcare entities cannot refuse to authorize or pay providers for providing these drugs and related services.